Extracorporeal total artificial heart as bailout surgery

Perrodin, Stéphanie; Müller, Olivier; Gronchi, Fabrizio; Liaudet, Lucas; Hullin, Roger; Kirsch, Matthias

doi:10.1111/jocs.13110

Cited by 2 publications

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The continuous evolution and utilization of the SynCardia Systems, LLC, TAH underscore its importance in improving patient care and outcomes, particularly for those with severe biventricular heart failure. The device's ability to provide comprehensive circulatory support by replacing both ventricles and cardiac valves has significantly contributed to enhancing patient outcomes and serving as a bridge to heart transplantation for individuals with end-stage heart failure [54].…”

Section: Total Artificial Heart Technologymentioning

confidence: 99%

Unveiling the future of cardiac care: advances in mechanical circulatory support

Tarcan

2024

J. mechatron., artif. intell., eng.

View full text Add to dashboard Cite

Congestive heart failure (CHF) is a multifaceted clinical syndrome characterized by the inability of the heart to pump blood effectively, leading to inadequate oxygen and nutrient delivery to the body tissues. Despite advancements in treatment strategies, including guideline-directed medical treatment (GDMT), end-stage CHF remains a significant cause of morbidity and mortality worldwide. Heart transplantation is considered to be the gold standard treatment of end stage CHF but constrained by the lack of organ donors, lengthening waitlists, and the negative side effects of lifelong immunosuppressive medications. Mechanical circulatory support (MCS) has emerged as a pivotal intervention for patients with end-stage CHF, serving as a bridge to recovery, transplantation, or destination therapy. The aim of this narrative review is to highlight the historical development of MCS, to assess the recent status of MCS device technology and discuss current challenges associated with complications of MCS that need to be solved in the future by device development. The history of MCS dates back to pioneering efforts in the 1960s, with significant progress in device development and utilization over decades. MCS devices, including left ventricular assist devices (LVADs), extracorporeal membrane oxygenation (ECMO), and artificial hearts, play a crucial role in providing circulatory support to patients with end-stage CHF. Recent advancements in MCS technology aim to decrease the device size, enhance blood compatibility, reduce thrombo-embolic complications, and prolong device durability and battery life and improve physiological performance of MCS. Continued research and innovation are essential to address these challenges and improve outcomes in patients with end-stage CHF. Artificial intelligence (AI) has emerged as a valuable tool in cardiovascular medicine to facilitate risk prediction, patient selection, and treatment optimization for MCS and heart transplantation. Despite these advancements, challenges persist in MCS device selection, resource allocation, and integration of AI into clinical practice. Continued research and innovation are essential to address these challenges and improve outcomes in patients with advanced heart failure.

show abstract

Section: Total Artificial Heart Technologymentioning

confidence: 99%

Unveiling the future of cardiac care: advances in mechanical circulatory support

Tarcan

2024

J. mechatron., artif. intell., eng.

View full text Add to dashboard Cite

show abstract

Transcutaneous Energy Transmission System for a Totally Implantable Artificial Heart Using a Two-Wire Archimedean Spiral Coil

Okinaga

Yamamoto

Koshiji

2021

2021 43rd Annual International Conference of the IEEE Engineering in Medicine &Amp; Biology Society (EMBC)

View full text Add to dashboard Cite

This paper describes the application of a proposed spiral coil to the transformer of a transcutaneous energy transfer system for a totally implantable artificial heart. To reduce the number of rectifier components in the power receiving circuit, the shape of the power receiving transformer was reviewed. The results indicated that the power transmission efficiency between the transformers was almost the same as that of the receiving transformer with the same shape. In addition, the calculations indicated that the power transmission efficiency including that of the power receiving circuit was increased, and the number of components in the power receiving circuit was reduced.Keywords-artificial heart, spiral coil, center tap, inductive power transfer, rectifying circuit.

show abstract

Extracorporeal total artificial heart as bailout surgery

Cited by 2 publications

References 14 publications

Unveiling the future of cardiac care: advances in mechanical circulatory support

Unveiling the future of cardiac care: advances in mechanical circulatory support

Transcutaneous Energy Transmission System for a Totally Implantable Artificial Heart Using a Two-Wire Archimedean Spiral Coil

Contact Info

Product

Resources

About